Surmodics (FRA:SU6) Long-Term Debt : €27.1 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Surmodics Long-Term Debt?

Surmodics's Long-Term Debt for the quarter that ended in Mar. 2024 was €27.1 Mil.

Surmodics's quarterly Long-Term Debt declined from Sep. 2023 (€27.6 Mil) to Dec. 2023 (€27.0 Mil) but then increased from Dec. 2023 (€27.0 Mil) to Mar. 2024 (€27.1 Mil).

Surmodics's annual Long-Term Debt stayed the same from Sep. 2021 (€0.0 Mil) to Sep. 2022 (€0.0 Mil) but then increased from Sep. 2022 (€0.0 Mil) to Sep. 2023 (€27.6 Mil).

Surmodics Long-Term Debt Historical Data

The historical data trend for Surmodics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics Long-Term Debt Chart

Surmodics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Long-Term Debt

Get a 7-Day Free Trial

27.55

Surmodics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															27.37	27.09	27.55	27.00	27.12

Surmodics (FRA:SU6) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Surmodics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Surmodics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Surmodics (FRA:SU6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (FRA:SU6) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SRDX:USA SU6:Germany

Address

9924 West 74th Street, Eden Prairie, MN, USA, 55344

Website

https://www.surmodics.com

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Surmodics (FRA:SU6) Headlines

No Headlines